Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 21 October 2020, 21:00 HKT/SGT
Share:
    

Source: Holista CollTech Ltd
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Top US-accredited Lab Confirms Path-Away(R) Natural Active Ingredient Kills the COVID-19 Virus within Two Minutes

Sydney, Kuala Lumpur, Bluffton, SC, Oct 21, 2020 - (ACN Newswire) - A leading US lab has released results confirming Path-Away®, a plant-based active ingredient that contains no chemicals or alcohol, can kill the virus that causes COVID-19 within two minutes. Path-Away's Anti Pathogenic Aerosol Solution was tested on SARS-CoV-2 by Microbac Laboratories, Inc., accredited by the U.S. Dept of Defence (DoD) and the Environmental Laboratory Accreditation Program (ELAP).

The Microbac tests were conducted using the direct inoculation method, and follow successful tests in an approved UK laboratory (April 2020) on the efficacy of Path-Away® against the feline coronavirus, a recognised surrogate of SARS-CoV-2. Path-Away® has also proven effective against a broad spectrum of microbes including SARS and H1N1 viruses.

Holista Colltech Ltd (ASX: HCT; Holista), the Asian-based distributor, and Global Infection Control Consultants, LLC (GICC LLC), the US-based developer, said the tests confirm Path-Away® as the world's first natural and safe organic disinfectant meeting U.S. testing standards. Holista distributes Path-Away® under its own NatShield™ and Protectene™ brands. Holista and GICC LLC are also co-developing NatShield™ nasal balm with Path-Away®, to launch before the end of 2020.

Holista also has rights to Path-Away® for use in aerosolised disinfection of buildings using a high-pressure fogger. The latest test results will significanly accelerate efforts to roll out the M3 System®, also developed by GICC LLC, which can disinfect large buildings by dispensing Path-Away® through heating, ventilation and air-conditioning (HVAC) systems to treat harmful pathogens, including airborne viruses.

GICC LLC recently secured a 36-month contract with the U.S. Govt to manufacture and install 10 million units of its M3 System® in large buildings. The system measures, monitors and contains airborne (aerosol) viruses, pathogens and other biological contaminants. Holista and GICC will form a 51:49 JV to manufacture the M3 System® in Singapore. Holista is exclusivel distributor of the M3 outside the US, China and Gulf States.

Dr Arthur V Martin, the president of GICC LLC, commented: "This is the first time an organic compound has been proven to kill the virus causing COVID-19, to 99.9% within two minutes. This will speed up the formal U.S. Government process of listing on the Environmental Protection Agency's (EPA) 'List N'. EPA expects products on List N to kill SARS-CoV-2 within two minutes. This will also allow for a wider use of this all-natural disinfectant for human use. The findings by Microbac also confirmed the effects of Path-Away® on other coronaviruses, which follows research showing COVID-19 survives on surfaces longer than scientists had originally calculated."

Dr. Roscoe Moore Jr., D.V.M., Ph.D., D.Sc., Former Assistant U.S. Surgeon and member of the Global Virus Network and its International COVID-19 Taskforce, said "There is a big need for natural and human friendly disinfectants that can be used frequently and safely without long term health side effects and while being environmentally safe. The recent tests from Microbac are most welcome as the public is looking for an agent that acts specifically against COVID-19". Dr Moore also chairs Holista's Scientific Advisory Board.

Dr Rajen Manicka, Chief Executive Officer of Holista, commented: "This product will address the significant untapped global market for all-natural disinfectants that are safe to be used on hands and faces. The results from Microbac will give our customers a greater level of confidence that NatShield™ and Protectene™ can be effective on skin, surfaces and as an aerosol, against the highly contagious COVID-19 causing virus.

"We have also fielded enquiries from large organisations to disinfect buildings and facilities with sizeable human traffic. We are preparing a submission to the Australian Therapeutic Goods Administration (TGA) for approval to label Natshield™ and Protectene™ as sanitizing and disinfectant products, as well as to have Natshield approved for aerosol delivery through fogging units and through HVAC systems in Australia."

Information on Path-Away® and Microbac Test Results

How Path-Away® Works:
Path-Away® attaches itself to the virus and inhibits its ability to take up amino acids - their basic building block. This forces the viruses to clump together, in the process killing themselves, almost instantly. The compound is environmentally safe with very low toxicity and does not harm humans and pets.

Test Results by Microbac:
- Cells containing the SARS-CoV-2 virus were seeded in 24-well plates and 2.0 mL (millilitres) of Path-Away® was added to the (live frozen samples - thawed out) dried virus inoculum and held for the contact time of 2 minutes at 21 degrees C with 53% relative humidity (RH). For the test to be deemed successful, Path-Away® must demonstrate a ≥ 3 Log10 reduction on each test carrier in the presence or absence of cytotoxicity.
- Path-Away® achieved this benchmark in each of the 24 instances (100% success rate). All controls met the criteria for a valid test and Microbac's conclusions are based on observed data.
- Log Reduction stands for a 10-fold (one decimal) or 90% reduction in numbers of live bacteria. A 3-Log Reduction equates to a 99.9% reduction - greater than 1,000 time reduction in potentially harmful microorganisms.
- Path-Away®, killed 99.9% (≥ 3 Log10) of the COVID-19 causing virus on a hard surface after being exposed to Path-Away®.
- The full test report and process will be featured on Holista's website at https://www.holistaco.com/

About Holista Colltech Limited
Holista Colltech Ltd (Holista) is a natural wellness company with Dietary supplements, Food Ingredients, Ovine collagen, and Infection Control Solutions. Holista has a global collaboration with Global Infection Control Consultants LLC to use Path-Away®, a plant-based solution that is proven to kill a broad spectrum of microbes, and the all-natural alcohol-free active ingredient used in Holista's range of disinfectant products under the NatShield™ brand.

For further information, please contact:
Corporate Matters: [email protected]
General Enquiries: [email protected]


Oct 21, 2020 21:00 HKT/SGT
Topic: Press release summary
Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Holista CollTech Ltd
Oct 1, 2020 15:00 HKT/SGT
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread
Apr 21, 2020 06:30 HKT/SGT
Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate
Apr 3, 2020 17:00 HKT/SGT
Skin Elements Enters Binding Agreement with Holista Colltech To Launch All Natural Skin-Friendly Sanitiser
Feb 20, 2020 16:00 HKT/SGT
Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets
Feb 6, 2020 16:00 HKT/SGT
Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of Deadly Disease
Jan 30, 2020 16:00 HKT/SGT
Orders for NatShield Sanitizer Spike after Outbreak of Coronavirus
Dec 13, 2019 13:00 HKT/SGT
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Fat-Soluble Nutraceuticals
Dec 12, 2019 12:00 HKT/SGT
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Other High-Value, Fat-Soluble Nutraceuticals
Nov 8, 2019 18:00 HKT/SGT
iGalen and Holista announce resolution with ATM Metabolics
Oct 18, 2019 14:45 HKT/SGT
Malaysian Companies Develop Ingredients for World's First Healthy Bubble Tea
More news >>
 News Alerts
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: